-1722511478674.svg){kind=small}
Published 16:37 IST, October 2nd 2024
Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug
Enzalutamide tablets are androgen receptor inhibitors indicated for the treatment of patients with castration-resistant prostate cancer.
The company has received tentative approval from USFDA to manufacture Enzalutamide tablets | Image:
Unsplash
- Listen to this article
- 1 min read
Advertisement
16:37 IST, October 2nd 2024